ArticleBMC women's health2025
Global socioeconomic inequalities in breast, cervical, ovarian, and uterine cancers incidence, mortality, disability-adjusted life year's rates: a relative concentration index analysis.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Ovarian cancer in Asia: incidence, mortality in 2022, and future projections to 2050.BMC public health · 2026Article
- Global Burden of Ovarian Cancer and Causal Risk Factors from 1990 to 2021: An Integrated GBD and Mendelian Randomization Analysis.International journal of women's health · 2026Article
- Female cancers in adolescent and young adult women: global inequities and 2050 burden estimates from GLOBOCAN 2022.Frontiers in oncology · 2026Article
- Association of TLR-4 and TLR-9 Polymorphisms with HPV Infection and Cervical Dysplasia in Hispanic Women.Cancers · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundsThis study examined the impact of the Human Development Index (HDI) on the incidence, mortality, and disability-adjusted life-year (DALY) rates of breast and gynecologic cancers in women worldwide.
methodsWe obtained the 2021 cancer rates by country from the Global Burden of Disease website. Using relative concentration indices and concentration curves, we measured socioeconomic inequality in the mortality, incidence, and DALY rates of these four cancers. We also grouped countries based on their socioeconomic status as measured by the Human Development Index.
resultsThe incidence, mortality, and DALY rates of uterine and ovarian cancer show higher values in countries with higher levels of HDI (all concentration indices were significantly higher than zero). On the other hand, the incidence, mortality and DALY rates of cervical cancer were more concentrated in countries with lower levels of HDI (all concentration indices were significantly less than zero). No socioeconomic inequality was observed in breast cancer mortality (RCI = 0, 95% confidence interval (CI) = -0.03 to 0.04), there was no significant inequality in breast cancer DALY rates (RCI = 0.02, 95% CI: -0.02 to 0.06), and only breast cancer incidence was significantly concentrated in countries with a high HDI (RCI = 0.09, 95% CI: 0.06 to 0.13).
conclusionOur study showed that socioeconomic inequalities exist in the distribution of mortality and morbidity from breast and gynecological cancers. Health care policies and facilities to reduce socioeconomic inequalities should focus on areas of high burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.